Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 3 Interventional

Study of LJP 394 in Lupus Patients With History of Renal Disease

ClinicalTrials.gov ID: NCT00089804

Public ClinicalTrials.gov record NCT00089804. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 10:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Three-Arm, Parallel-Group, Multicenter, Multinational Safety and Efficacy Trial of 300 mg and 900 mg of Abetimus Sodium in Systemic Lupus Erythematosus (SLE) Patients With a History of Renal Disease

Study identification

NCT ID
NCT00089804
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 3
Lead sponsor
La Jolla Pharmaceutical Company
Industry
Enrollment
943 participants

Conditions and interventions

Interventions

  • abetimus sodium (LJP 394) and/or placebo solution Drug
  • abetimus sodium (LJP 394) Drug
  • Phosphate-buffered saline Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2004
Primary completion
Jan 31, 2009
Completion
Jan 31, 2009
Last update posted
Mar 31, 2009

2004 – 2009

United States locations

U.S. sites
32
U.S. states
17
U.S. cities
31
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Wallace Rheumatic Study Center Los Angeles California 90048
East Bay Rheumatology Medical Group San Leandro California 94578
Private Practice San Mateo California 94401
CRIA Research Fort Lauderdale Florida 33334
Miami Children's Hospital Miami Florida 33155
Emory University School of Medicine, Renal Division Atlanta Georgia 30322
Private Practice Augusta Georgia 30909
Southeast Regional Research Group Savannah Georgia 31406
Intermountain Orthopedics Boise Idaho 83702
Rheumatology Associates Chicago Illinois 60612
Ochsner Clinic Foundation New Orleans Louisiana 70121
SOMARC Trials, LLC Greenbelt Maryland 20770
Nephrology Associates, PC Flushing New York 11355
North Shore - LIJ Health System Lake Success New York 11042
Feinstein Institute for Medical Research Manhasset New York 11030
Seligman Center for Advanced Therapeutics, NYU Hospital for Joint Diseases New York New York 10003
AAIR Research Center Rochester New York 14618
Suny Upstate Medical University Syracuse New York 13210
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
Ohio State University Medical Center Columbus Ohio 43210
Healthcare Research Consultants Tulsa Oklahoma 74135
Private Practice Camp Hill Pennsylvania 17011
Altoona Center for Clinical Research Duncansville Pennsylvania 16635
Arthritis Clinic, 371 North Parkway, Suite 400 Jackson Tennessee 38305
Amarillo Center for Clinical Research Amarillo Texas 79124
Miracle Medical Clinic, 1170 Blalock Road Houston Texas 77055
Renal Care Clinic, P.A., 17202 Red Oak Drive Houston Texas 77090
Texas Tech University Health Sciences Center Lubbock Texas 79430
San Antonio Kidney Disease Center San Antonio Texas 78229
Clinical Research & Consulting Center Fairfax Virginia 22030
Arthritis Northwest PLLC Spokane Washington 99204

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 169 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00089804, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 31, 2009 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00089804 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →